Globus Medical
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +60.7% | -1.6% | +3.8% | -0.6% | +5.0% | -9.0% | +24.6% | +3.2% | +7.5% | -8.1% | +3.9% | – | |
| – | +96.1% | -9.0% | +7.7% | +4.0% | -2.6% | -25.8% | +27.3% | +13.5% | -18.1% | +1.2% | +3.1% | – | |
| – | +41.4% | +4.0% | +1.2% | -3.9% | +10.9% | +2.3% | +23.3% | -2.0% | +22.3% | -11.7% | +4.3% | – | |
| – | +78.2% | +9.6% | -34.2% | -6.1% | -5.6% | -1.0% | +20.8% | -4.7% | +94.2% | -50.6% | -0.5% | – | |
| – | +56.7% | +1.6% | -4.3% | +1.1% | +5.3% | -4.2% | +25.1% | +3.3% | +1.6% | -6.5% | -3.7% | – | |
| – | +37.6% | +4.8% | -10.4% | -4.0% | +8.6% | -8.4% | +37.5% | -16.4% | +20.4% | -14.1% | +0.5% | – | |
| – | +2,405.7% | -21.0% | +520.5% | -3.1% | +25.3% | +60.9% | -21.5% | +77.4% | +27.2% | -4.7% | +11.5% | – | |
| – | -67.4% | -26.6% | +23.3% | -66.8% | +5.2% | – | – | +110.0% | – | – | – | – | |
| – | +886.0% | -134.2% | – | +19.9% | -56.7% | +320.3% | +81.5% | -23.5% | +20.9% | -9.8% | +20.8% | – | |
| – | +548.0% | -114.5% | – | -67.2% | -135.4% | – | -152.0% | – | +33.6% | -2.0% | +16.7% | – | |
| – | +1,406.4% | -147.3% | – | +63.2% | -48.9% | +184.7% | +168.8% | -41.4% | +18.2% | -11.6% | +21.9% | – | |
| – | +12.5% | -12.7% | +49.0% | -8.3% | +25.3% | +13.0% | +17.9% | +11.2% | +13.6% | -7.1% | -16.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.